Fig. 3
From: Azvudine efficacy in reducing mortality in COVID-19 patients

28-day mortality rate of various clinical types in COVID-19 patients. A Mild. B Moderate. C Severe. D Critical
From: Azvudine efficacy in reducing mortality in COVID-19 patients
28-day mortality rate of various clinical types in COVID-19 patients. A Mild. B Moderate. C Severe. D Critical